Stay updated on GSK2857916 Two Doses in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A supplementary MedlinePlus Genetics reference related to multiple myeloma was removed from the study page.
    Difference
    0.1%
    Check dated 2026-11-15T02:12:36.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for this completed multiple myeloma study is displayed, including its study design, eligibility criteria, outcomes, locations, and supporting documents, in place of the error page.
    Difference
    100%
    Check dated 2026-11-08T04:59:07.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T02:10:51.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces updates to terminology during the transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T02:07:12.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:55:22.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T02:32:13.000Z thumbnail image

Stay in the know with updates to GSK2857916 Two Doses in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.